The numbers indicate the report chapter that corresponds to, explains, and analyzes each channel flow. The chart below illustrates the depth and breadth of the 2023 edition.
Download a free report overview for more details on the new sections and content. What’s more, 35 of the exhibits in the 2023 edition include new data sources that have not been used in previous editions. There are 241 exhibits in the 2023 edition, compared with 216 in the 2022 edition. In Subsection 12.5.2., we highlight potential implications of the IRA for the drug channel. In Subsection 12.5.1., we summarize the key provisions of the law that relate to the topics in this report. addresses the Inflation Reduction Act of 2022. This 2023 edition includes substantial new material. Material that addresses COVID-19 and its impact on the pharmacy and PBM industries has been integrated into our analyses throughout the report. Throughout the report, we have added new industry data, deepened our coverage of many topics, and added more trending information. Pharmacies and Pharmacy Benefit Managers is a definitive, nonpartisan resource that includes the most current information about pharmacy dispensing channels, third-party payers, pharmacy benefit managers (PBMs), patients’ financial contributions, government regulations, and much more.Īs always, we have updated all market and industry data with the most current information available, including our annual analyses of the market positions of the largest pharmacies, specialty pharmacies, and PBMs. Special preorder and launch pricing discounts will be valid through April 3, 2023.
Click here to email us if you would like to pay by corporate purchase order or check. You can pay online with all major credit cards (Visa, MasterCard, American Express, and Discover) or via PayPal.
(including key industry trends, the Table of Contents, and a List of Exhibits). CLICK HERE to download a free pre-publication overview
0 kommentar(er)
